Top Supermarket Stocks To Own For 2015: Cytokinetics Incorporated(CYTK)
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The company?s cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was f ounded in 1997 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Rick Munarriz]
Tuesday
Cytokinetics (NASDAQ: CYTK ) checks in on Tuesday. The biotech company's lead candidate is a cardiac muscle contractility program that Cytokinetics is trying to get approved for the potential treatment of heart failure. Investors see red ink here, but analysts do see the quarterly deficit narrowing this time around. - [By Rich Duprey]
Biopharmaceutical Cytokinetics (NASDAQ: CYTK ) announced yesterday that it will be effecting a 1-for-6 reverse stock split to reduce the number of outstanding shares from approximately 163.6 million to approximately 27.3 million shares.
source from Top Stocks For 2015:ht! tp://www.topstocksblog.com/top-supermarket-stocks-to-own-for-2015.html
No comments:
Post a Comment